Cytokinetics Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Focus Intensifies ADT Inc Q1 2026 Earnings EPS Beat Bolsters Margins Despite Revenue Discreetness COYA Q1 2026 Earnings NarrowerthanExpected Loss as Biotech Advances Pipeline VTEX Q1 2026 Earnings EPS Miss Sends Shares Lower Amid Revenue Uncertainty ATLCL Q1 2026 Earnings Strong EPS Beat Signals Improved Profitability EYPT Q1 2026 Earnings EPS Misses Estimates as Clinicalstage Biotech Advances Pipeline